Sandoz Gets Approval For US Pegfilgrastim

Becomes First To Offer Both Long- And Short-Acting Biosimilars

 
• By Akriti Seth
Paper_Planes
Sandoz will become the only company in US to offer both long- and short-acting filgrastim biosimilars • Source: Shutterstock

More from Biosimilars

More from Products